LBT acts as a specific topoisomerase IIβ poison and has been studied extensively in a range of cancer cell types in vitro and tumor types in vivo, such as LXFS538, CXF280, PAXF546, MCF7X, and LXFA526 cells, as well as 21 human tumor xenografts [21]. Here, TOP2B is linked to neoplasm.